Medtronic plc (MDT) earnings date, results and what the price requires
NYSE · SEC CIK 0001613103 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jul 31, 2026 | Sep 1, 2026 | $9.76B | $1.47B | $1.14 | Filing |
| Apr 24, 2026 | Jun 3, 2026 | $9.81B | $-3.56B | $0.96 | Filing |
| Jan 23, 2026 | Feb 17, 2026 | $9.02B | $1.14B | $0.89 | Filing |
| Oct 24, 2025 | Nov 18, 2025 | $8.96B | $1.37B | $1.07 | Filing |
| Jul 25, 2025 | Aug 19, 2025 | $8.58B | $1.04B | $0.81 | Filing |
| Apr 25, 2025 | May 21, 2025 | $8.93B | $-3.61B | $0.81 | Filing |
| Jan 24, 2025 | Feb 18, 2025 | $8.29B | $1.29B | $1.01 | Filing |
| Oct 25, 2024 | Nov 19, 2024 | $8.40B | $1.27B | $0.99 | Filing |
What would Medtronic plc have to report for its valuation to change?
At $95.45, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 15.0% a year, to $8.16. On that path the next quarter needs diluted EPS near $1.23, against $1.07 in the quarter ended Oct 24, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 15.0% | 15.0% |
| EPS needed in final year | $8.16 | $8.16 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. MDT goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.